A Chinese biotechnology firm will start constructing its plant for plasma fractionation in Bangladesh soon. This will be the first biotechnology plant in the country.
The biotech plasma fractionation plant will be built at the Block II of Bangabandhu Hi-Tech City in Gazipur with a cost of US $300 million, concerned officials said.
Summit Technopolis, a subsidiary of Summit Group, has already developed the land for the plant.
"Within six months after tripartite agreement signing, we handed over the possession of 25 acres of land to Oryx Bio-tech for setting up the plasma fractionation plant," said an official of Summit.
Prior to handing over, Summit Technopolis completed extensive land improvement with an additional Tk 51.4 million (Tk 5.14 crore) investment to meet the critical requirements for the development of the country's first biotechnology plant, he added.
Oryx Bio-tech is a subsidiary of Oryx Biotech Holdings based in China and it is expected that about 2,000 high-value science graduates will be employed when the plant will kick off operation in 2023.
Oryx Biotech Holdings, parent company of Oryx Bio-tech Ltd., is also a China-based biological product developer.
Summit Technopolis Ltd. is the concessionaire for developing infrastructure for hi-tech industry in the 91 acres area at Bangabandhu Hi-Tech City in Gazipur.
